Clinical Trials Directory

Trials / Unknown

UnknownNCT05163444

Gait Analysis of Hemiparetics Adults Patients With Quadripod Cane and Rolling Cane

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Liege · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

After stroke, a lot of patients present an hemiparesis and gait disorders. They need walking aids like quadripod cane or rolling cane. The quadripod cane confers a great stability but implies a walk in 3 times, thus consume more energy. The pause time necessary for the displacement (uplift) of the cane disappear with the Wheeleo. The investigators will study many spatio-temporal parameters to determine which one allows to decrease the walking speed.

Detailed description

Hemiparesis affects 65% of stroke patients and cause gait disorders. During rehabilitation, patients often need technical aids to the the return to walk. For example, they can use the quadripod cane and the rolling cane, called Wheeleo. Regarding the first one, as its name indicate, there are 4 feet while the other model has 4 wheels. Deltombe and al. proved that the walking speed is higher with a rolling cane. The investigators will recruited stroke patients and study many spatio-temporal parameters with a gait analysis system, when participants are walking with the two walking aids. Participants will achieve 6 minutes walking test and a 10 meters walking test, with a wearable inertial systems on their shoes. The investigators wish to reveal which spatio-temporal parameters most influence walking speed.

Conditions

Interventions

TypeNameDescription
DEVICEGait analysis with rolling cane6 minutes walking test 10 meters walking test Before this experimentation, we will fix wearables sensors on the shoes.
DEVICEGait analysis with quadripod cane6 minutes walking test 10 meters walking test Before this experimentation, we will fix wearables sensors on the shoes.

Timeline

Start date
2022-02-26
Primary completion
2023-03-31
Completion
2023-03-31
First posted
2021-12-20
Last updated
2022-05-24

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05163444. Inclusion in this directory is not an endorsement.